AZ eyes China's 'explosion' of innovation for cell therapy fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.
M&A dealmaking in the pharmaceutical and biotechnology industry is on the rise, signaling increased confidence and a focus on growth amid challenges. Read more here.
Shares of Fusion Pharmaceuticals Inc. (NASDAQ:FUSN – Get Free Report) have earned a consensus rating of “Hold” from the fourteen analysts that are presently covering the firm, MarketBeat reports. Thirteen equities research analysts have rated the stock with a hold rating and one has issued a buy rating on the company. The average 12 month […]
Q1 Canadian VC funding posts mixed results as PE market rebounds, CVCA reports betakit.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from betakit.com Daily Mail and Mail on Sunday newspapers.